In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Customers are to be offered discounted weight loss treatments through insurance giant Vitality in a UK first. The group, ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...

Children who lost enough weight to no longer be considered obese had similar reductions in risk, and also experienced a 60% ...

Novo Nordisk reported Q4 sales of $11.96 billion, beating estimates. The company plans a new phase 3 trial for CagriSema in ...

If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your body to burn more fat instead and hang on to muscle. There’s also a ...

Embarking on the quest to lose weight can be a risky business. Yo-yo dieting, compulsive binging, muscle wasting and brain ...

Drugmakers have poured small fortunes into the development of weight loss medicines in the past ... In short, Novo Nordisk is a solid long-term pick. Don’t miss this second chance at a ...

Wegovy is a GLP-1 agonist containing ... 85% of participants lost weight. A long-term study found 56% of participants achieved significant weight loss after one year, and half maintained it ...